Lipid second messengers. A role in cell growth regulation and cell cycle progression.
Strum
J C
JC
Glaxo Wellcome Inc., Research Triangle Park, North Carolina 27709, USA.
Ghosh
S
S
Bell
R M
RM
D000818:Animals; D002264:Carboxylic Acids / Q000494:pharmacology; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D002518:Ceramides / Q000502:physiology*; D037341:Fumonisins; D006863:Hydrogen-Ion Concentration; D008540:Meiosis / Q000187:drug effects; D008563:Membrane Lipids / Q000502:physiology; D016297:Mutagenesis, Site-Directed; D009865:Oocytes / Q000166:cytology / Q000187:drug effects; D010712:Phosphatidic Acids / Q000502:physiology*; D010743:Phospholipids / Q000502:physiology*; D011374:Progesterone / Q000494:pharmacology; D019908:Proto-Oncogene Proteins c-raf / Q000502:physiology*; D015290:Second Messenger Systems / Q000502:physiology*; D013107:Sphingolipids / Q000494:pharmacology; D013108:Sphingomyelin Phosphodiesterase / Q000502:physiology; D013110:Sphingosine / Q000378:metabolism; D014982:Xenopus laevis
D002264:Carboxylic Acids; D002518:Ceramides; D037341:Fumonisins; D008563:Membrane Lipids; D010712:Phosphatidic Acids; D010743:Phospholipids; D013107:Sphingolipids; C056933:fumonisin B1; D011374:Progesterone; D019908:Proto-Oncogene Proteins c-raf; D013108:Sphingomyelin Phosphodiesterase; D013110:Sphingosine